With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.301224-40-8,(1,3-Dimesitylimidazolidin-2-ylidene)(2-isopropoxybenzylidene)ruthenium(VI) chloride,as a common compound, the synthetic route is as follows.
C765 was synthesized according to the procedure described in US 2014/0371454. C765 was isolated as red/brown crystals in 97.1% yield
As the paragraph descriping shows that 301224-40-8 is playing an increasingly important role.
Reference£º
Patent; MATERIA, INC.; CALIFORNIA INSTITUTE OF TECHNOLOGY; JOHNS, Adam, M.; MONTGOMERY, T., Patric; AHMED, Tonia, S.; GRUBBS, Robert, H.; PEDERSON, Richard, L.; (95 pag.)WO2017/100585; (2017); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI